Sequenom, Illumina Ink Supply Agreement

The firms have formalized a supply deal, under which Sequenom and its subsidiaries will purchase Illumina sequencing products for use in developing its non-invasive trisomy 21 test.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.